Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)
| dc.contributor.author | Price, David | |
| dc.contributor.author | Henley, William | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Skinner, Derek | |
| dc.contributor.author | Vella, Rebecca | |
| dc.contributor.author | Papi, Alberto | |
| dc.contributor.author | Fabbri, Leonardo M | |
| dc.contributor.author | Kerstjens, Huib AM | |
| dc.contributor.author | Roche, Nicolas | |
| dc.contributor.author | Singh, Dave | |
| dc.contributor.author | Vogelmeier, Claus F | |
| dc.contributor.author | Şen, Elif | |
| dc.contributor.author | Delfini Cançado, José Eduardo | |
| dc.contributor.author | Nudo, Elena | |
| dc.contributor.author | Barile, Sara | |
| dc.contributor.author | Georges, George | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-08-14T14:01:01Z | |
| dc.date.available | 2024-08-14T14:01:01Z | |
| dc.date.issued | 2021-09-05 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 101041 | |
| dc.identifier | 292526855 | |
| dc.identifier | c89e8b02-12dd-4445-8d8b-884fc0cf047c | |
| dc.identifier.citation | Price, D, Henley, W, Carter, V, Skinner, D, Vella, R, Papi, A, Fabbri, L M, Kerstjens, H AM, Roche, N, Singh, D, Vogelmeier, C F, Şen, E, Delfini Cançado, J E, Nudo, E, Barile, S & Georges, G 2021, 'Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)', European Respiratory Journal, vol. 58, no. Suppl. 65, PA560. https://doi.org/10.1183/13993003.congress-2021.PA560 | en |
| dc.identifier.doi | 10.1183/13993003.congress-2021.PA560 | |
| dc.identifier.issn | 0903-1936 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24033 | |
| dc.identifier.vol | 58 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Respiratory Journal | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD) | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Price_etal_ERS_Pneumonia_Risk_In_AAM.pdf
- Size:
- 98.67 KB
- Format:
- Adobe Portable Document Format
